Skip to content
healthcare.dev

AMLODIPINE BESYLATE

NDC 69097-126, AMLODIPINE BESYLATE, tablet, from Cipla USA Inc..

Product NDC
69097-126
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077073
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-126 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMLODIPINE BESYLATE2.5 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]

Package NDCNDC-11Package
69097-126-056909701260590 TABLET in 1 BOTTLE (69097-126-05)
69097-126-15690970126151000 TABLET in 1 BOTTLE (69097-126-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5409b296-3bed-47cd-abba-9fe6f6833af6
  • NADAC price for package 69097012605

    GET /v1/drugs/nadac/69097012605
  • NADAC price for package 69097012615

    GET /v1/drugs/nadac/69097012615

Use it

Look up 69097-126 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-126 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-126. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.